(Q34215306)

31 July 2017

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (English)

1 reference

ESMO Guidelines Working Group

31 July 2017

1 reference

8

object named as

ESMO Guidelines Working Group

1 reference

31 July 2017

N Colombo

1

1 reference

31 July 2017

E Preti

2

1 reference

31 July 2017

F Landoni

3

1 reference

31 July 2017

S Carinelli

4

1 reference

31 July 2017

A Colombo

5

1 reference

31 July 2017

C Marini

6

1 reference

31 July 2017

C Sessa

7

1 reference

31 July 2017

1 September 2011

1 reference

31 July 2017

1 reference

31 July 2017

22 Suppl 6

1 reference

31 July 2017

vi35-9

1 reference

Diagnostic strategies for postmenopausal bleeding

31 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Radiologic staging in patients with endometrial cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Advances in magnetic resonance imaging of endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Unresolved issues in the management of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Developments in the systemic treatment of endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR374

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDR374

1 reference

31 July 2017

1 reference